|
 |
Science > Leukemia
The following information is about Leukemia.
Leukemia Defined
Cancer of the blood-forming parts of the body, especially the bone marrow and the spleen. It is characterized by an abnormal increase of white blood cells.
This definition is in context to Science. See more contextual defintions for Leukemia.
Dicerna Pharmaceuticals Appoints Leading Experts to Scientific Advisory Board
Published October 15, 2008, 6:05 am, Centre Daily Times
Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), announced today the appointment of leading experts to its Scientific Advisory Board (SAB). The newly appointed SAB will serve as a strategic asset to the company as it continues to develop novel RNAi-based therapies ...
Aldagen, Inc. Appoints Lyle Hohnke, Ph.D. to Board of Directors
Published October 15, 2008, 6:00 am, Marketwire via Yahoo! Finance
Aldagen, Inc. today announced the appointment of Lyle Hohnke, Ph.D. to its Board of Directors. Dr. Hohnke has over 35 years of health care industry experience, focusing on biotechnology, pharmaceuticals and medical devices. He has been a partner of Tullis Dickerson, a healthcare focused venture capital fund, since 1994 and currently serves on the board of several private and public companies.
CytRx Corporation's 45% Owned Affiliate RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for ...
Published October 15, 2008, 5:52 am, Centre Daily Times
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that its 45% owned affiliate RXi Pharmaceuticals Corporation has licensed exclusive worldwide rights from the University of Massachusetts Medical School (UMMS) to certain technology for the oral delivery of RNAi therapeutics. The technology was ...
CytRx Corporation's 45% Owned Affiliate RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for ...
Published October 15, 2008, 5:30 am, Business Wire via Yahoo! Finance
LOS ANGELES----CytRx Corporation , a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that its 45% owned affiliate RXi Pharmaceuticals Corporation has licensed exclusive worldwide rights from the University of Massachusetts Medical School to certain technology for the oral delivery of RNAi therapeutics.
Dicerna Pharmaceuticals Appoints Leading Experts to Scientific Advisory Board
Published October 15, 2008, 5:30 am, Business Wire via Yahoo! Finance
WATERTOWN, Mass.----Dicerna Pharmaceuticals, Inc. , a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology™, announced today the appointment of leading experts to its Scientific Advisory Board .
Physicians Favor Stem Cell Research; Disagree on Ethical Issues at the Heart of the Debate
Published October 15, 2008, 12:01 am, PRWeb via Yahoo! News
Physicians who generally favor advancement of stem cell research in terms of its actual or potential benefits don't always agree on the ethical issues at the heart of the stem cell research debate, according to a recent survey commissioned by Jackson & Coker.
GTx Announces Investigational Ostarine™ (MK-2866) Met The Primary Endpoint In Phase II Cancer Cachexia Clinical Trial ...
Published October 14, 2008, 12:08 pm, Medical News Today
GTx, Inc. (NASDAQ: GTXI) today announced topline results of a Phase II clinical trial evaluating Ostarine™ (MK-2866), an investigational selective androgen receptor modulator (SARM), in patients with cancer induced muscle loss, also known as cancer cachexia.
Friday Edition: A Primer on the Stem Cell Debate
Published October 13, 2008, 9:48 pm, Poynter Institute
The stem cell story is coming back in full next week, starting Monday. With the threat of a presidential veto hanging over it, the Senate is about to vote on a package of bills that would encourage the federal government to conduct and fund embryonic stem cell research .
Drugmaker to support Lawrence startup
Published October 13, 2008, 9:12 pm, The Kansas City Star
Eli Lilly and Co. has forged a partnership in the quest for new cancer treatments that could bring $520 million to Lawrence's Deciphera Pharmaceuticals.
Researchers meet today on cancer cluster data
Published October 13, 2008, 4:55 pm, Reno Gazette-Journal
Researchers from the University of Nevada, Reno; the University of California, San Francisco; and the University of Arizona meet today at at UNR to discuss various aspects of their research surrounding the Fallon child leukemia cluster that occurred several years ago. Some city and county officials were expected to attend.
Are you looking for additional Science > Leukemia news? Try our new "Leukemia News Focus" area.
Off-site Leukemia Links, User Submitted
The following links have been collected through user bookmark submission in the Leukemia category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Wed Oct 15
- Leukemia & Lymphoma Society - Chronic Lymphocytic Leukemia
- Viva! Acai Berry Juice - Health Benefits
- ???? ????? - ????? ???? ??????????
Mon Oct 13
- Leukemia
- Richard Todd's 44-Day Victory over Leukemia
- The Leukemia & Lymphoma Society
- Welcome to TACL!
- Leukemia - Wikipedia, the free encyclopedia
Fri Oct 10
- Whitecourt Star - Study links cancer, nuclear power: A German study linking increased cancer rates in children with their proximity to nuclear power plants raised some eyebrows at the Blue Ridge Community Hall last week. Tipping Point, a Whitecourt-bas ed anti-nuclear group invited German pediatrician Dr. Ernst Iskenius to present the results of the KiKK study to about 30 Whitecourt and Woodland County residents. The KiKK study was the second of two released by the German government last fall. Its results created a public outcry and debate, which is still continuing today in Europe. The first German study, published by Terschueren Hoffmann and D.B. Richardson found 14 cases of leukemia between 1990 and 2005 in children living within five kilometres from the Krummel nuclear plant in Geesthacht and another northern facility in Germany. Annotated link http://www.dii go.com/bookmar k/http%3A%2F%2 Fwww.whitecour tstar.com%2FAr ticleDisplay.a spx%3Fe%3D1241 010
- Study looks at leukemia deaths - | Tri-City Herald: A new study of Hanford and other nuclear defense site workers found exposure to low levels of radiation slightly increased the risk that workers would die of leukemia. The study was conducted by the National Institute for Occupational Safety and Health, a federal research agency, and looked at doses that a worker at a nuclear site might receive over a lifetime of work. Previous studies that look at a correlation between exposure and leukemia typically have looked at higher levels of exposure, according to NIOSH.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Leukemia. If you would like to find related tags we recommend Tag Patterns > Leukemia
Off-site Leukemia Research Links
If you still need additional information on Leukemia then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Science Topics
Everything you need to know about Science
Science
If you know the Science Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Science.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.